Morphea and systemic sclerosis are associated with an increased risk for melanoma and nonmelanoma skin cancer

J Am Acad Dermatol. 2019 May;80(5):1449-1451. doi: 10.1016/j.jaad.2018.10.022. Epub 2018 Oct 21.

Authors

Emily Boozalis¹, Ami A Shah², Fredrick Wigley², Sewon Kang¹, Shawn G Kwatra³

Affiliations

¹ Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Scleroderma Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: skwatra1@jhmi.edu.

PMID: 30352282
DOI: 10.1016/j.jaad.2018.10.022

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Basal Cell / epidemiology*
Carcinoma, Squamous Cell / epidemiology*
Comorbidity
Female
Humans
Male
Melanoma / epidemiology*
Prevalence
Retrospective Studies
Risk Factors
Scleroderma, Localized / epidemiology*
Scleroderma, Systemic / epidemiology*
Skin Neoplasms / epidemiology*